CPAP Devices Market Projected To Grow By USD 1.33 Billion From 2024-2028 Fueled By AI's Role In Addressing Sleep Apnea And Respiratory Disorders - Technavio


(MENAFN- PR Newswire) NEW YORK, Oct. 14, 2024 /PRNewswire/ -- Report with market evolution powered by AI - The Global Continuous Positive Airway Pressure (CPAP) Devices Market
size is estimated to grow by USD 1.33 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of about
6.35%
during the forecast period. Increasing prevalence of sleep apnea and respiratory disorders
is driving market growth,
with a trend towards
increasing number of partnerships and collaborations. However,
frequent product recalls
poses a challenge - Key market players include BMC MEDICAL CO. LTD., CASCO BAY MOLDING, Compumedics Ltd., DeVilbiss Healthcare GmbH, Dragerwerk AG and Co. KGaA, Ess Pee Enterprises, Fisher and Paykel Healthcare Corp. Ltd., Hamilton Co., Koninklijke Philips N.V., Lowenstein Medical Technology GmbH and Co. KG, Manish Enterprises, Medtronic, Narang Medical Ltd., NXP Semiconductors NV, ResMed Inc., Sleepnet Corp., Smiths Group Plc, TG Eakin Ltd., The Cleveland Clinic Foundation, and Vyaire Medical Inc..

Continue Reading

Technavio has announced its latest market research report titled Global continuous positive airway pressure (CPAP) devices market 2024-2028

AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View your snapshot now

Forecast period

2024-2028

Base Year

2023

Historic Data

2018 - 2022

Segment Covered

Product (Devices and Accessories), Distribution Channel (Offline and Online), and Geography (North America, Europe, Asia, and Rest of World (ROW))

Region Covered

North America, Europe, Asia, and Rest of World (ROW)

Key companies profiled

BMC MEDICAL CO. LTD., CASCO BAY MOLDING, Compumedics Ltd., DeVilbiss Healthcare GmbH, Dragerwerk AG and Co. KGaA, Ess Pee Enterprises, Fisher and Paykel Healthcare Corp. Ltd., Hamilton Co., Koninklijke Philips N.V., Lowenstein Medical Technology GmbH and Co. KG, Manish Enterprises, Medtronic, Narang Medical Ltd., NXP Semiconductors NV, ResMed Inc., Sleepnet Corp., Smiths Group Plc, TG Eakin Ltd., The Cleveland Clinic Foundation, and Vyaire Medical Inc.

Key Market Trends Fueling Growth

The CPAP devices market is experiencing significant growth due to an increasing number of partnerships and collaborations between vendors and medical technology companies. These strategic alliances enable vendors to expand their distribution channels and enhance their product offerings by integrating software tools into their devices. For instance, Compumedics' collaboration with Radiometer Pacific includes the addition of the TCM5 flex transcutaneous monitor to Compumedics' sleep diagnostic solutions. Similarly, ResMed has partnered with Verily to develop software solutions for sleep apnea and other respiratory disorders. Philips Respironics has also collaborated with Inspire Medical Systems to create an implantable device for sleep apnea. These collaborations are beneficial for patients and the healthcare industry, as they lead to the development of innovative solutions that improve patient outcomes and reduce the burden of respiratory disorders on healthcare systems . Overall, the growing trend of partnerships and collaborations in the CPAP devices market is expected to drive market growth during the forecast period.

The Continuous Positive Airway Pressure (CPAP) devices market in the medical devices sector is experiencing significant growth due to the increasing demand for alternative treatments for sleep disorders like Sleep Apnea and Hypopnea Syndrome. The aging population and rising healthcare spending are key drivers, expanding the patient pool. CPAP devices are increasingly being used as ventilator substitutes in hospital settings and home care , addressing health risks related to cardiovascular disease and sleep services. Innovative therapies like Mandibular Advancing Devices and Heated Humidifiers enhance patient comfort. Reimbursement policies, remote patient monitoring , and telemedicine facilitate home-based treatment. Noise reducing technology and FDA emergency policies ensure safety and patient compliance. Product segmentation includes different types of CPAP machines, masks, and accessories. However, contamination risks and aerosolization are challenges to be addressed.

Insights on how AI is driving innovation, efficiency, and market growth- Request Sample!

Market
Challenges

  • The medical device industry, including Continuous Positive Airway Pressure (CPAP) devices, is subject to product recalls due to safety and functionality concerns. Regulatory authorities, such as the US Food and Drug Administration (FDA), play a crucial role in updating the Medical Device Recall Database following a company's correction or recall of their equipment. Manufacturers initiate recalls when their products require modification or removal from the market due to various reasons, including design errors, software issues, manufacturing defects, and labeling mistakes. In 2023, Philips Respironics recalled certain reworked DreamStation CPAP and BiPAP machines due to potential inaccurate or insufficient therapy delivery. The FDA classified this as a Class I recall, the most serious type, as the use of these devices could lead to serious injuries or death. In 2021, Royal Philips recalled CPAP and Bi-Level PAP Devices due to degraded PE-PUR sound abatement foam, which could enter the air pathway and be inhaled or ingested, causing potential lung injury or impairment. Product recalls can significantly impact the growth of the global CPAP devices market during the forecast period. These incidents underscore the importance of rigorous quality control and regulatory compliance in the manufacturing and distribution of medical devices.
  • The Continuous Positive Airway Pressure (CPAP) devices market is experiencing significant growth due to the rising prevalence of sleep disorders such as Sleep Apnea and Hypopnea Syndrome. The geriatric population is a major consumer group, as these conditions are common among older adults. However, challenges include ensuring patient comfort, integrating heated humidifiers, and addressing telemedicine and home-based treatment in home care settings. FDA's emergency policy and the use of CPAPs as ventilator substitutes pose new regulations. Contamination risks and patient compliance are concerns, while product segmentation includes manual and automatic devices for adult and pediatric patients. Comorbidities like obesity, hypertension, diabetes, cardiovascular diseases, depression, and sleep disorders increase the market potential. Virtual care, insurance coverage, and competition from reverse engineering are key factors. CPAPs are essential for treating Obstructive Sleep Apnea, reducing mortality from respiratory disorders, and improving life expectancy.

Insights into how AI is reshaping industries and driving growth-
Download a Sample Report

Segment Overview

This continuous positive airway pressure (cpap) devices market report extensively covers market segmentation by

  • Product
    • 1.1 Devices
    • 1.2 Accessories
  • Distribution Channel
    • 2.1 Offline
    • 2.2 Online
  • Geography
    • 3.1 North America
    • 3.2 Europe
    • 3.3 Asia
    • 3.4 Rest of World (ROW)

    1.1
    Devices-
    The Continuous Positive Airway Pressure (CPAP) devices market is growing due to the increasing prevalence of sleep apnea and other respiratory disorders. These devices provide constant air pressure through a mask to keep airways open during sleep, improving breathing and reducing sleep disturbances. Major players in the market include ResMed, Philips Respiratory Care, and Fisher & Paykel Healthcare. Market growth is driven by technological advancements, rising healthcare expenditures, and growing awareness about sleep disorders.

    Download complimentary Sample Report to gain insights into AI's impact on market dynamics, emerging trends, and future opportunities- including forecast (2024-2028) and historic data (2018 - 2022)

    Research Analysis

    The Continuous Positive Airway Pressure (CPAP) devices market is witnessing significant growth due to the rising prevalence of sleep disorders such as Sleep Apnea and Hypopnea Syndrome, particularly in the geriatric population. These respiratory assistance therapies are essential for treating Obstructive Sleep Apnea, a respiratory disorder characterized by repeated pauses in breathing during sleep. The undiagnosed and treated sleep apnea cases are increasing, leading to a higher demand for CPAP devices. Factors such as unhealthy dietary habits, obesity, comorbidities like hypertension, and physical inactivity contribute to the development of sleep apnea. Patient comfort is a critical factor in the adoption of CPAP devices, leading to advancements in technology such as Heated Humidifiers and Noise Reducing Technology. Telemedicine and home-based treatment are also gaining popularity in home care settings. Alternative treatments like Mandibular Advancing Devices and ventilators are available, but CPAP devices remain the gold standard due to their effectiveness and ease of use. The market for CPAP devices is expected to grow significantly due to the aging population, increasing healthcare spending, and the high mortality rate associated with untreated sleep apnea. Cardiovascular disease is a significant comorbidity, making the use of CPAP devices crucial for managing respiratory disorders and reducing healthcare costs.

    Market Research Overview

    The Continuous Positive Airway Pressure (CPAP) devices market caters to the growing prevalence of sleep disorders such as Sleep Apnea and Hypopnea Syndrome, particularly in the geriatric population. Patient comfort is a significant factor in the market, leading to the integration of technologies like Heated Humidifiers and Telemedicine for home-based treatment in home care settings. Infusion therapy and FDA emergency policies have expanded the use of CPAP devices as ventilator substitutes. However, concerns over aerosolization and contamination risks persist, affecting patient compliance. Product segmentation includes Manual and Automatic CPAP devices, with Adult Patients and Pediatric patients being the primary consumer groups. Hospitals and Private Clinics are major end-users, while Competitive Pricing, Reverse Engineering, and Alternative treatments like Mandibular Advancing Devices pose challenges. Comorbidities such as Obesity, Hypertension, Diabetes, Cardiovascular diseases, Depression, and unhealthy dietary habits contribute to the rising patient pool. Healthcare spending, aging population, and public health initiatives are key drivers, with Sleep services, Innovative therapies, and Reimbursement policies shaping the market landscape. Remote Patient Monitoring and Noise Reducing Technology are essential features in the evolving CPAP devices market.

    Table of Contents:

    1 Executive Summary
    2 Market Landscape
    3 Market Sizing
    4 Historic Market Size
    5 Five Forces Analysis
    6 Market Segmentation

    • Product
      • Devices
      • Accessories
    • Distribution Channel
      • Offline
      • Online
    • Geography
      • North America
      • Europe
      • Asia
      • Rest Of World (ROW)

    7 Customer Landscape
    8 Geographic Landscape
    9 Drivers, Challenges, and Trends
    10 Company Landscape
    11 Company Analysis
    12 Appendix

    About Technavio

    Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

    With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

    Contacts

    Technavio Research
    Jesse Maida
    Media & Marketing Executive
    US: +1 844 364 1100
    UK: +44 203 893 3200
    Email:
    [email protected]
    Website:

    SOURCE Technavio

    WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
    Newsrooms &
    Influencers 9k+
    Digital Media
    Outlets 270k+
    Journalists
    Opted In GET STARTED

    MENAFN14102024003732001241ID1108777922


  • PR Newswire

    Legal Disclaimer:
    MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.